Tectonic Therapeutic, Company Insiders
| TECX Stock | 47.56 0.12 0.25% |
Tectonic Therapeutic,'s insiders are aggressively buying. The analysis of the overall insider sentiment regarding Tectonic Therapeutic, suggests that vertually all insiders are extremely bullish. Tectonic Therapeutic, employs about 44 people. The company is managed by 9 executives with a total tenure of roughly 103 years, averaging almost 11.0 years of service per executive, having 4.89 employees per reported executive.
Tectonic Therapeutic,'s Insider Buying Vs Selling
100
Selling | Buying |
Latest Trades
| 2024-10-22 | Timothy A Springer | Acquired 300000 @ 33.59 | View | ||
| 2024-09-26 | Timothy A Springer | Acquired 50000 @ 28.82 | View |
Monitoring Tectonic Therapeutic,'s insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Tectonic |
Tectonic Therapeutic, Management Team Effectiveness
Return On Tangible Assets is likely to drop to -0.44 in 2024. Return On Capital Employed is likely to drop to -0.49 in 2024. At this time, Tectonic Therapeutic,'s Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 931.4 K in 2024, whereas Non Current Assets Total are likely to drop slightly above 790.4 K in 2024. Tectonic Therapeutic,'s management efficiency ratios could be used to measure how well Tectonic Therapeutic, manages its routine affairs as well as how well it operates its assets and liabilities.Common Stock Shares Outstanding is likely to rise to about 3.8 M in 2024
Tectonic Therapeutic, Workforce Comparison
Tectonic Therapeutic, is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 1,563. Tectonic Therapeutic, holds roughly 44.0 in number of employees claiming about 2.82% of equities under Health Care industry.
Tectonic Therapeutic, Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Tectonic Therapeutic, insiders, such as employees or executives, is commonly permitted as long as it does not rely on Tectonic Therapeutic,'s material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Tectonic Therapeutic, insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Marc Schwabish over two weeks ago Acquisition by Marc Schwabish of 2000 shares of Tectonic Therapeutic, at 2.38 subject to Rule 16b-3 | ||
Reicin Alise over two weeks ago Acquisition by Reicin Alise of 6000 shares of Tectonic Therapeutic, at 51.28 subject to Rule 16b-3 | ||
Ruddy Marcella K. over three weeks ago Acquisition by Ruddy Marcella K. of 18704 shares of Tectonic Therapeutic, at 5.38 subject to Rule 16b-3 | ||
Springer Timothy A over three months ago Acquisition by Springer Timothy A of 186134 shares of Tectonic Therapeutic, subject to Rule 16b-3 | ||
Reicin Alise over three months ago Acquisition by Reicin Alise of 33923 shares of Tectonic Therapeutic, at 2.38 subject to Rule 16b-3 | ||
Ruddy Marcella K. over six months ago Acquisition by Ruddy Marcella K. of 18704 shares of TECX at 5.38 subject to Rule 16b-3 |
Tectonic Therapeutic, Notable Stakeholders
A Tectonic Therapeutic, stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Tectonic Therapeutic, often face trade-offs trying to please all of them. Tectonic Therapeutic,'s stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Tectonic Therapeutic,'s stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Daniel MBA | Chief Officer | Profile | |
| MS MD | Chief Officer | Profile | |
| Christian Cortis | Executive Officer | Profile | |
| Peter McNamara | Chief Officer | Profile | |
| Anthony MD | Chief Officer | Profile | |
| John Diener | Senior Sciences | Profile | |
| Marc Schwabish | Chief Officer | Profile | |
| Marcella MD | Chief Officer | Profile | |
| Barry MS | Senior Culture | Profile |
About Tectonic Therapeutic, Management Performance
The success or failure of an entity such as Tectonic Therapeutic, often depends on how effective the management is. Tectonic Therapeutic, management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Tectonic management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Tectonic management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.42) | (0.44) | |
| Return On Capital Employed | (0.47) | (0.49) | |
| Return On Assets | (0.42) | (0.44) | |
| Return On Equity | (0.45) | (0.47) |
Please note, the imprecision that can be found in Tectonic Therapeutic,'s accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Tectonic Therapeutic,. Check Tectonic Therapeutic,'s Beneish M Score to see the likelihood of Tectonic Therapeutic,'s management manipulating its earnings.
Tectonic Therapeutic, Workforce Analysis
Traditionally, organizations such as Tectonic Therapeutic, use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Tectonic Therapeutic, within its industry.Tectonic Therapeutic, Manpower Efficiency
Return on Tectonic Therapeutic, Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 973.2K | |
| Net Loss Per Executive | 4.8M | |
| Working Capital Per Employee | 663.8K | |
| Working Capital Per Executive | 3.2M |
Additional Tools for Tectonic Stock Analysis
When running Tectonic Therapeutic,'s price analysis, check to measure Tectonic Therapeutic,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tectonic Therapeutic, is operating at the current time. Most of Tectonic Therapeutic,'s value examination focuses on studying past and present price action to predict the probability of Tectonic Therapeutic,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tectonic Therapeutic,'s price. Additionally, you may evaluate how the addition of Tectonic Therapeutic, to your portfolios can decrease your overall portfolio volatility.